Theresa May während der Münchener Sicherheitskonferenz 2018.
Montag, 10.04.2017 22:10 von | Aufrufe: 53

Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

Theresa May während der Münchener Sicherheitskonferenz 2018. Foto: Kuhlmann / MSC (https://commons.wikimedia.org/wiki/File:Theresa_May_MSC_2018.jpg), „Theresa May MSC 2018“, Zuschnitt von ARIVA.DE, https://creativecommons.org/licenses/by/3.0/de/legalcode

PR Newswire

AUSTIN, Texas, April 10, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2017 on Monday, May 1, 2017. A press release announcing the results is scheduled for release after the close of trading on that date.

Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2017 on May 1, 2017, at 4:30 p.m. Eastern time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Us section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

The use of pop-up blocking software may impair your ability to view webcasts. If you use this software, press and hold the CTRL key when you click on the Register button. Please contact your IT group if you are unable to override this feature. Unauthorized recording or downloading of this event is not permitted.

About Luminex Corporation

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.  We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.

Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO 
hcurrie@luminexcorp.com


ARIVA.DE Börsen-Geflüster

Kurse

-  
0,00%
Luminex Chart

Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-corporation-first-quarter-earnings-release-scheduled-for-may-1-2017-300437371.html

SOURCE Luminex Corporation

Werbung

Mehr Nachrichten zur Luminex Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News